1. Home
  2. NTLA vs FLNG Comparison

NTLA vs FLNG Comparison

Compare NTLA & FLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • FLNG
  • Stock Information
  • Founded
  • NTLA 2014
  • FLNG 2006
  • Country
  • NTLA United States
  • FLNG Bermuda
  • Employees
  • NTLA N/A
  • FLNG N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • FLNG Marine Transportation
  • Sector
  • NTLA Health Care
  • FLNG Consumer Discretionary
  • Exchange
  • NTLA Nasdaq
  • FLNG Nasdaq
  • Market Cap
  • NTLA 1.2B
  • FLNG 1.3B
  • IPO Year
  • NTLA 2016
  • FLNG N/A
  • Fundamental
  • Price
  • NTLA $12.06
  • FLNG $25.77
  • Analyst Decision
  • NTLA Buy
  • FLNG Hold
  • Analyst Count
  • NTLA 20
  • FLNG 1
  • Target Price
  • NTLA $32.30
  • FLNG $23.00
  • AVG Volume (30 Days)
  • NTLA 4.2M
  • FLNG 498.1K
  • Earning Date
  • NTLA 08-07-2025
  • FLNG 08-20-2025
  • Dividend Yield
  • NTLA N/A
  • FLNG 11.63%
  • EPS Growth
  • NTLA N/A
  • FLNG N/A
  • EPS
  • NTLA N/A
  • FLNG 1.83
  • Revenue
  • NTLA $52,857,000.00
  • FLNG $355,837,000.00
  • Revenue This Year
  • NTLA $8.32
  • FLNG N/A
  • Revenue Next Year
  • NTLA N/A
  • FLNG $3.41
  • P/E Ratio
  • NTLA N/A
  • FLNG $14.82
  • Revenue Growth
  • NTLA 14.99
  • FLNG N/A
  • 52 Week Low
  • NTLA $5.90
  • FLNG $19.46
  • 52 Week High
  • NTLA $23.76
  • FLNG $27.67
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 60.10
  • FLNG 49.01
  • Support Level
  • NTLA $11.29
  • FLNG $26.52
  • Resistance Level
  • NTLA $12.46
  • FLNG $27.15
  • Average True Range (ATR)
  • NTLA 0.56
  • FLNG 0.60
  • MACD
  • NTLA 0.12
  • FLNG -0.09
  • Stochastic Oscillator
  • NTLA 84.85
  • FLNG 32.89

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About FLNG FLEX LNG Ltd.

Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with tonnage offering advantages in form of reduced fuel consumption and lowered boil-off rates.

Share on Social Networks: